Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529174 · ClinicalTrials.gov registry record · NA
Oral Nutritional Supplement Effect on HDL Function
A NA study, sponsored by Metagenics.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04529174 is a NA study that has completed, run by Metagenics. The registered enrollment target is 53 participants.
The verdict
NCT04529174, a NA study, has completed, sponsored by Metagenics.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
Evaluate the effects of a proprietary supplement on total HDL, HDL functionality, HDL particle size and HDL particle number (HDL-P)
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT CardioLux™HDL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-08-18 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04529174
The ClinicalTrials.gov registry entry for NCT04529174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metagenics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04529174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04529174 about?
NCT04529174 is a clinical study titled "Oral Nutritional Supplement Effect on HDL Function". Evaluate the effects of a proprietary supplement on total HDL, HDL functionality, HDL particle size and HDL particle number (HDL-P)
What is the current status of trial NCT04529174?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2020-08-18. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT04529174?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), CardioLux™HDL (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04529174?
This trial is sponsored by Metagenics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.